| 2026-03-31 |
详情>>
股本变动：
变动后总股本704.98万股
|
| 2026-03-31 |
详情>>
业绩披露：
2025年年报每股收益0.59美元,归母净利润361.10万美元,同比去年增长57.00%
|
| 2026-03-31 |
财报披露：
美东时间 2026-03-31 盘前发布财报
|
| 2025-11-25 |
详情>>
业绩披露：
2025年三季报(累计)每股收益0.46美元,归母净利润279.20万美元,同比去年增长53.83%
|
| 2025-09-30 |
详情>>
业绩披露：
2025年中报每股收益0.36美元,归母净利润211.40万美元,同比去年增长70.21%
|
| 2025-09-03 |
股东大会：
将于2025-10-23召开股东大会
会议内容 ▼▲
- 1.To elect each of the following persons to serve as directors on the Company’s Board of Directors (the “Board”) for such term as set forth below, and until his successor has been duly elected and qualified:
Avi Dadon — for a term of 3 years (Class C);
Eyal Cohen — for a term of 3 years (Class C).
2.To ratify and approve the indemnification and exemption arrangement for directors and officers.
3.To approve a bonus to the CEO.
4.To appoint Fahn Kanne & Co. Grant Thornton Israel, as the Company’s Independent Auditors for the year ending December 31, 2025, and for such additional period until the next annual general meeting of shareholders.
5.To review the Auditor’s Report and the Company’s Consolidated Financial Statements for the fiscal year ended December 31, 2024.
|
| 2025-05-29 |
详情>>
业绩披露：
2025年一季报每股收益0.23美元,归母净利润135.10万美元,同比去年增长82.32%
|
| 2025-03-31 |
详情>>
业绩披露：
2022年年报每股收益0.23美元,归母净利润127.60万美元,同比去年增长182.93%
|
| 2025-03-31 |
详情>>
业绩披露：
2024年年报每股收益0.40美元,归母净利润230.00万美元,同比去年增长14.71%
|
| 2024-11-27 |
详情>>
业绩披露：
2024年三季报(累计)每股收益0.32美元,归母净利润181.50万美元,同比去年增长14.95%
|
| 2024-10-15 |
股东大会：
将于2024-12-05召开股东大会
会议内容 ▼▲
- 1.To elect the following person to serve as a director on the Company’s Board of Directors (the “Board”) for such terms as set forth below, and until her successor has been duly elected and qualified:Osnat Gur – for a term of 3 years.
2.To approve an amendment to the Company’s Articles of Association, as provided in this Proxy Statement, to conform to amendments to the Israeli Companies Regulations.
3.To approve an increase to the CEO’s salary.
4.To approve a bonus to the CEO.
5.To approve the grant of 15,000 options to purchase Ordinary Shares to re-elected and newly elected directors.
6.To appoint Fahn Kanne & Co. Grant Thornton Israel, as the Company’s Independent Auditors for the year ending December 31, 2024, and for such additional period until the next annual general meeting of shareholders.
7.To review the Auditor’s Report and the Company’s Consolidated Financial Statements for the fiscal year ended December 31, 2023.
|
| 2024-09-30 |
详情>>
业绩披露：
2024年中报每股收益0.22美元,归母净利润124.20万美元,同比去年增长-1.9%
|
| 2024-05-30 |
详情>>
业绩披露：
2024年一季报每股收益0.13美元,归母净利润74.10万美元,同比去年增长12.96%
|
| 2024-04-01 |
详情>>
业绩披露：
2023年年报每股收益0.35美元,归母净利润200.50万美元,同比去年增长57.13%
|
| 2023-10-31 |
股东大会：
将于2023-12-07召开股东大会
会议内容 ▼▲
- 1.To elect the following to serve as a director on the Company’s Board of Directors (the “Board”) for such term as set forth below, and until his successor has been duly elected and qualified:Yaron Eldad – for a term of 3 years (Class B).
2.To approve an extension of the 2003 Israeli Share Option Plan, as amended.
3.To approve the Company’s Compensation Policy, including new clawback provisions required by the Nasdaq Stock Market.
4.To appoint Fahn Kanne & Co. Grant Thornton Israel, as the Company’s Independent Auditors for the year ending December 31, 2023, and for such additional period until the next annual general meeting of shareholders.
5.To review the Auditor’s Report and the Company’s Consolidated Financial Statements for the fiscal year ended December 31, 2022.
|
| 2023-10-31 |
股东大会：
将于2023-12-14召开股东大会
会议内容 ▼▲
- 1.To elect the following to serve as a director on the Company’s Board of Directors (the “Board”) for such term as set forth below, and until his successor has been duly elected and qualified:Yaron Eldad – for a term of 3 years (Class B).
2.To approve an extension of the 2003 Israeli Share Option Plan, as amended.
3.To approve the Company’s Compensation Policy, including new clawback provisions required by the Nasdaq Stock Market.
4.To appoint Fahn Kanne & Co. Grant Thornton Israel, as the Company’s Independent Auditors for the year ending December 31, 2023, and for such additional period until the next annual general meeting of shareholders.
5.To review the Auditor’s Report and the Company’s Consolidated Financial Statements for the fiscal year ended December 31, 2022.
|
| 2022-11-03 |
股东大会：
将于2022-12-15召开股东大会
会议内容 ▼▲
- 1.To elect the following to serve as a director on the Company’s Board of Directors (the “Board”) for such terms as set forth below, and until his successor has been duly elected and qualified:Ziv Dekel — for a term of 3 years (Class C);Yaron Eldad — for a term of 1 year (Class B);and Eyal Cohen — for a term of 3 years (Class C).
2.To approve an increase of the Company’s authorized share capital by 3 million ordinary shares.
3.To approve an increase of the number of Ordinary Shares available for issuance under the 2003 Israeli Share Option Plan, by 300,000 to a total of 1,000,000.
4.To approve the grant of 80,000 options to the CEO.
5.To appoint Fahn Kanne & Co. Grant Thornton Israel, as the Company’s Independent Auditors for the year ending December 31, 2022, and for such additional period until the next annual general meeting of shareholders.
6.To review the Auditor’s Report and the Company’s Consolidated Financial Statements for the fiscal year ended December 31,2021.
|
| 2021-10-14 |
股东大会：
将于2021-10-21召开股东大会
会议内容 ▼▲
- 1.To elect the following to serve as a director on the Company’s Board of Directors (the “Board”) for such terms as set forth below, and until her successor has been duly elected and qualified: Osnat Gur – for a term of 3 years (Class A);
2.To ratify and approve the indemnification and exemption arrangements for directors and officers.
3.To approve the grant of options to the CEO;
4.To appoint Fahn Kanne & Co. Grant Thornton Israel, as the Company’s Independent Auditors for the year ending December 31, 2021, and for such additional period until the next annual general meeting of shareholders.
5.To review the Auditor’s Report and the Company’s Consolidated Financial Statements for the fiscal year ended December 31, 2020.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-09-03 |
股东大会：
将于2021-10-14召开股东大会
会议内容 ▼▲
- 1.To elect the following to serve as a director on the Company’s Board of Directors (the “Board”) for such terms as set forth below, and until her successor has been duly elected and qualified: Osnat Gur – for a term of 3 years (Class A);
2.To ratify and approve the indemnification and exemption arrangements for directors and officers.
3.To approve the grant of options to the CEO;
4.To appoint Fahn Kanne & Co. Grant Thornton Israel, as the Company’s Independent Auditors for the year ending December 31, 2021, and for such additional period until the next annual general meeting of shareholders.
5.To review the Auditor’s Report and the Company’s Consolidated Financial Statements for the fiscal year ended December 31, 2020.
|
| 2021-05-19 |
复牌提示：
2021-05-19 11:17:07 停牌，复牌日期 2021-05-19 11:22:07
|
| 2020-11-04 |
股东大会：
将于2020-12-16召开股东大会
会议内容 ▼▲
- 1.To re-elect and elect (as applicable) the following to serve as directors on the Company’s Board of Directors for such terms as set forth below, and until their successors have been duly elected and qualified:
a.Ralph Sassun — for a term of 3 years (Class A);
b.Michael Osborne — for a term of 3 years (Class A);
c.Eyal Cohen — for a term of 2 years (Class B).1
2.To approve the New Compensation Policy;
3.To approve the grant of options to the Company’s Chairman;
4.To approve the cancellation of the nominal value of the Company’s Ordinary Shares;
5.To approve an increase of the Company’s authorized share capital;
6.To appoint Fahn Kanne & Co. Grant Thornton Israel, as the Company’s Independent Auditors for the year ending December 31, 2020, and for such additional period until the next annual general meeting of shareholders.
7.To review the Auditor’s Report and the Company’s Consolidated Financial Statements for the fiscal year ended December 31, 2019.
|
| 2019-10-24 |
股东大会：
将于2019-10-31召开股东大会
会议内容 ▼▲
- 1.To amend the Company’s Articles of Association to give effect to the following:
1.1A change in the Board members nomination mechanism such that directors shall be elected only at the Company’s annual shareholders meeting, and not at a special meeting
1.2Introducing a classified board nomination mechanism, according to which, every year only a 1/3 of the Board members will be nominated and elected
1.3A change in the size of the Board, to consist of between 4 and 7 directors
1.4The annual shareholders meeting may remove a director by a vote 65% of the shareholders actually voting at the shareholders meeting
1.5Amendments to the Articles of Association with respect to the Board composition shall require the approval of 65% of the shareholders actually voting at the shareholders meeting
2.To approve the change in the Company’s name to BOS Ltd and effect corresponding amendments to the Company’s Memorandum of Association and Articles of Association.
3.To re-elect and elect (as applicable), the following to serve as directors on the Company’s Board of Directors, for such terms as set forth below (subject to approval of proposal 1), and until their successors have been duly elected and qualified:
a.Yosi Lahad — for a term of 3 years
b.Ziv Dekel — for a term of 3 year;
c.Odelia Levanon — for a term of 2 years;
d.Revital Cohen — for a term of 2 years;
e.Ralph Sassun — for a term of 1 year;
f.Michael Osborne — for a term of 1 year.
In the event proposal 1 is not adopted, the term of service of the elected or re-elected directors shall be one year and until their successors have been duly elected and qualified.
4.To approve the New Compensation Policy.
5.To approve the 2019 Compensation Plans of the Company’s Executive Officers.
6.To approve the Directors’ compensation for non-employee directors (excluding the Chairman), for the term of their tenure.
7.To approve the 2019-2021 compensation plan for the Company’s Chairman
8.To ratify and approve liability insurance covering the Company’s directors and officers, as described in the Proxy Statement.
9.To appoint Fahn Kanne & Co. Grant Thornton Israel, as the Company’s Independent Auditors for the year ending December 31, 2019, and for such additional period until the next annual general meeting of shareholders.
10.To review the Auditor’s Report and the Company’s Consolidated Financial Statements for the fiscal year ended December 31, 2018.
|
| 2019-03-07 |
股东大会：
将于2019-04-11召开股东大会
会议内容 ▼▲
- 1.To remove from office, immediately upon the closing of the general meeting of the shareholders, each of the following current serving directors: Mr. Yuval Viner, Mr. Yosi Lahad, Mr. Avidan Zelicovsky, Ms. Odelia Levanon, Mr. Ziv Dekel, Ms. Revital Cohen and Mr. Ralph Sassun;
2.To elect each of the following Pure Capital nominees: Eli Yoresh, Itschak Shrem, Lior Amit, Liron Carmel and Dr. Hedva Voliovitch, to serve as members of the board of directors of the Company until the next annual general meeting of shareholders and until their successors have been duly elected and qualified.
|
| 2018-07-11 |
股东大会：
将于2018-07-18召开股东大会
会议内容 ▼▲
- 1.To re-elect Yosi Lahad, Odelia Levanon, Avidan Zelicovsky, Yuval Viner, Revital Cohen and Ziv Dekel and to elect Menachem Shmool to serve as directors on the Company’s Board of Directors, until the next annual general meeting of shareholders and until their successors have been duly elected and qualified.
2.To approve an increase in the authorized share capital and to amend the Company’s Memorandum of Association and Articles of Association, accordingly.
3.To approve an amendment of the 2003 Israeli Share Option Plan and an increase to the number of shares available for issuance thereunder.
4.To approve the New Compensation Policy.
5.To approve the 2018 Compensation Plans of the Company’s Executive Officers.
6.To approve an additional grant of shares to Executive Officers and Active Chairman in connection with a contemplated acquisition.
7.To ratify and approve the indemnification and exemption arrangements for directors and officers (excluding the CEO).
8.To ratify and approve the indemnification and exemption arrangement for the CEO.
9.To appoint Fahn Kanne & Co. Grant Thornton Israel, as the Company’s Independent Auditors for the year ending December 31, 2018, and for such additional period until the next annual general meeting of shareholders.
10.To review the Auditor’s Report and the Company’s Consolidated Financial Statements for the fiscal year ended December 31, 2017.
|
| 2017-12-05 |
股东大会：
将于2017-12-12召开股东大会
会议内容 ▼▲
- 1.To re-elect Yosi Lahad, Odelia Levanon, Avidan Zelicovsky, Yuval Viner, David Golan and Ziv Dekel, and to elect Revital Cohen, to serve as directors on the Company’s Board of Directors, until the next annual general meeting of shareholders and until their successors have been duly elected and qualified.
2.To approve an increase in the authorized share capital and to amend the Company’s Memorandum of Association and Articles of Association, accordingly.
3.To approve an increase to the number of options available for issuance under the Company’s 2003 Israeli Share Option Plan.
4.To approve the compensation and a grant of options for the Company’s directors who are not employees or service providers (except for the Active Chairman).
5.To approve the 2017-2018 compensation plan for the Active Chairman.
6.To approve the 2017 compensation plan for the President.
7.To approve the 2017 compensation plan for the Company's Co-CEO (Yuval Viner).
8.To approve the 2017 compensation plan for Company's Co-CEO and CFO (Eyal Cohen).
9.To appoint Fahn Kanne, a member of Grant Thornton, as the Company's Independent Auditors for the year ending December 31, 2017, and for such additional period until the next annual general meeting of shareholders.
10.To review the Auditor's Report and the Company's Consolidated Financial Statements for the fiscal year ended December 31, 2016.
|
| 2016-11-08 |
股东大会：
将于2016-11-08召开股东大会
会议内容 ▼▲
- 1. To re-elect Yosi Lahad, Odelia Levanon, Avidan Zelicovsky, Yuval Viner and Ziv Dekel, and to elect Moti Harel to the Company’s Board of Directors, until the next annual general meeting of shareholders and until their successors have been duly elected and qualified.
2. To approve certain amendments to the Company's Compensation Policy.
3. To approve the compensation for the Company's Chairman.
4. To approve for the Company’s Chief Executive Officer: (a) a bonus plan for 2016; and (b) the grant of options to purchase 10,000 of the Company’s Ordinary Shares.
5. To approve for the Company's President: (a) a bonus plan for 2016; and (b) the grant of options to purchase 10,000 of the Company's Ordinary Shares.
6. To approve an increase to the number of options available for issuance under the Company’s 2003 Israeli Share Option Plan.
7. To reappoint Kost, Forer, Gabbay, and Kasierer, a member of Ernst & Young International Ltd., as the Company's Independent Auditors for the year ending December 31, 2016; and for such additional period until the next annual general meeting of shareholders.
|